Arca
Skip to content

Traumatic brain injury

Drug research and approvals for traumatic brain injury: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 16, 2026, 375 studies of traumatic brain injury are recruiting on ClinicalTrials.gov, Health Canada has authorized 12 drug trials for it since 2013, and FDA has 0 approved and 4 open orphan designations naming it.

  • Recruiting worldwide: 375
  • Trials authorized in Canada: 12
  • FDA orphan approvals: 0
  • EU medicines: 0

Recruiting Now

Newest start dates first, of 375 recruiting on ClinicalTrials.gov ↗

Trials Authorized in Canada

The 10 newest of 12; search them all in Canada trials
Aug 15, 2025Brainapt – tbi international adaptative platform trialMETOPROLOL / PROPRANOLOL / PHENYTOIN / LEVETIRACETAMCHU DE QUÉBEC-UNIVERSITÉ LAVALOngoing
Oct 10, 2024Psilocybin-assisted therapy for chronic traumatic brain injuryPSILOCYBINROOTS TO THRIVEPending
Sep 26, 2023Effects of dexmedetomidine on agitation in critically ill tbi patients (dex-tbi)DEXMEDETOMIDINECIUSSS DU NORD-DE-L'ILE-DE-MONTRÉAL - HÔPITAL DU SACRÉ-COEUR DE MONTRÉAL.Ongoing
May 22, 2019Prospective, randomized, double-blind, placebo-controlled, multicenter study to investigate the efficacy and safety of nt 201 in the treatment of lower limb…XEOMIN (NT 201)Merz GroupClosed
Sep 26, 2018Mao-b imaging in traumatic brain injury[11C]-SL25.1188 INJPET CENTRE CENTRE FOR ADDICTION AND MENTAL HEALTHOngoing
Jul 19, 2018Hyperbaric oxygen brain injury treatment (hobit) trial: a multicenter, randomized, prospective phase II adaptive clinical trial evaluating the most effective…OXYGENMINNEAPOLIS MEDICAL RESEARCH FOUNDATIONOngoing
May 11, 2017Prophylaxis for venous thromboembolism in severe traumatic brain injury, a double-blind randomized controlled trialFRAGMIN / LOVENOX / HEPARINSUNNYBROOK RESEARCH INSTITUTEOngoing
Nov 26, 2015Mechanism of amantadine and functional improvement following acquired brain injury as measured by mri tractography; a pilot studyAMANTADINEHAMILTON HEALTH SCIENCES CORPORATIONPending
Apr 23, 2015Prehospital tranexamic acid use for traumatic brain injuryTRANEXAMIC ACIDDR JIM CHRISTENSONOngoing
Mar 20, 2014Prehospital tranexamic acid use for traumatic brain injuryTRANEXAMIC ACIDST MICHAELS HOSPITALClosed

FDA Orphan Designations

Approved first, then open designations, newest first
Nov 23, 2010cyclosporine; ciclosporinTreatment of moderate to severe traumatic brain injury.Owl TherapeuticsDesignated
May 23, 2006Apomorphine hydrochlorideFor the treatment of patients in a vegetative state or minimally conscious state for up to 12 months following a severe traumatic brain…NeuroHealing Pharmaceuticals, Inc.Designated
Apr 15, 2005AnatibantTreatment of patients having experienced a severe traumatic brain injury (Glasgow Coma Scale 3 to 8) in order to decrease early mortality…Xytis, Inc.Designated
Aug 11, 2004dexanabinolFor the attenuation or amelioration of the long-term neurological sequelae associated with moderate and severe traumatic brain injuryPharmos CorporationDesignated

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.